Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast vs Azithromycin in Severe COPD
NCT07795086Phase 4Not yet recruiting
- Sponsor
- Sidra Aziz
- Start
- Feb 2027
- Primary completion
- Feb 2027
01
Overview
A Phase 4 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by Sidra Aziz. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07795086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07795086.